Table 5.
Study | ICU | AMS protocols | Outcomes |
---|---|---|---|
Johansson et al., 2011[87] | General ICU | Antimicrobial consumption Hygiene precautions |
Improvement in antibiotic use |
Hou et al., 2014[88] | General ICU | Antimicrobial consumption Antibiotic stop-order |
Reduced antibiotic consumption Significantly improved antibiotic resistance |
Ruiz et al., 2017[89] | Medical ICU | Antimicrobial consumption Feedback |
Reduced antimicrobial use |
Kitano et al., 2019[90] | Neonatal | Daily antimicrobial management Antibiotic stop-order Weekend report of blood culture result |
Significantly reduced antimicrobial prescriptions |
Jones et al., 2019[91] | Pediatric ICU | Piperacillin–tazobactam consumption AMS team Positive feedback |
Broad-spectrum antimicrobial consumption |
Devchand et al., 2019[92] | Mixed medico-surgical ICU | Electronic medical records 5 “moments” of antimicrobial prescribing (escalation, de-escalation, discontinuation, switch, and optimization) |
High clinician compliance with recommendations Improved rates of choosing the right antibiotic |
Quirós et al., 2022[93] | Multicenter, medical ICU | Antimicrobial consumption, appropriateness of antimicrobial treatments, crude mortality, and MDR-resistant microorganisms in healthcare-associated infections | Significant improvement in antimicrobial utilization |
AMS: Antimicrobial stewardship; ICUs: Intensive care units; MDR: multidrug-resistant.